Outcomes of patients with atrial fibrillation on oral anticoagulation with and without heart failure: the ETNA-AF-Europe registry

AIMS: Heart failure (HF) is a risk factor for major adverse events in atrial fibrillation (AF). Whether this risk persists on non-vitamin K antagonist oral anticoagulants (NOACs) and varies according to left ventricular ejection fraction (LVEF) is debated. METHODS AND RESULTS: We investigated the re...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnabel, Renate B, Ameri, Pietro, Siller-Matula, Jolanta M, Diemberger, Igor, Gwechenberger, Marianne, Pecen, Ladislav, Manu, Marius Constantin, Souza, José, De Caterina, Raffaele, Kirchhof, Paulus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540669/
https://www.ncbi.nlm.nih.gov/pubmed/37713182
http://dx.doi.org/10.1093/europace/euad280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540669/
https://www.ncbi.nlm.nih.gov/pubmed/37713182
http://dx.doi.org/10.1093/europace/euad280

Ejemplares similares